Recent Quotes (30 days)

You have no recent quotes
chg | %

Promis Neurosciences Inc  

(Public, TSE:PMN)   Watch this stock  
Find more results for TSE:AMF
0.0000 (0.00%)
Delayed:   1:06PM EDT
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.05 - 0.05
52 week 0.04 - 0.12
Open 0.05
Vol / Avg. 282,698.00/284,352.00
Mkt cap 6.90M
P/E     -
Div/yield     -
EPS -0.02
Shares 170.36M
Beta -0.96
Inst. own     -
Aug 11, 2016
Q2 2016 Promis Neurosciences Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 11, 2016
Q1 2016 Promis Neurosciences Inc Earnings Release
Mar 23, 2016
Q4 2015 Promis Neurosciences Inc Earnings Release

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -9279.19% -
Operating margin -9212.48% -
EBITD margin - -
Return on average assets -302.86% -
Return on average equity -2794.90% -
CDP Score - -


Suite 200, 1920 Yonge Street
+1-416-8476898 (Phone)
+1-416-8476899 (Fax)

Website links


ProMIS Neurosciences Inc., formerly Amorfix Life Sciences Ltd., is a Canada-based development-stage biotech company. The Company discovers and develops precision therapeutics with companion diagnostics for early detection and treatment of neurodegenerative diseases, in particular Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). The assays are developed using its technologies, Epitope Protection and AMFIA. It is developing therapies targeting misfolded, neurotoxic forms of Amyloid beta in AD and superoxide dismutase 1 (SOD1) in ALS. The Company focuses to use its platform to discover further targets for precision medicine solutions through identification of target epitopes on other misfolded strains of Amyloid beta. The Company focuses to evaluate targets on misfolded strains of tau, another protein implicated in neurodegenerative diseases, including Alzheimer's. The Company has not generated any product revenues.

Officers and directors

Eugene Williams Executive Chairman of the Board
Elliot Goldstein M.D. President, Chief Executive Officer, Director
Age: 65
Neil Cashman M.D. Co-Founder, Chief Scientific Officer, Director
Janet Clennett Director - Finance, Acting Chief Financial Officer
Steven S. Plotkin Ph.D. Chief Physics Officer
Robert Gundel Ph.D. Director
Johannes M. Roth Independent Director
Age: 36